New SARS-CoV-2 Antibody Test Determines Previous Covid-19 Infection in 1.5 Hours
The Randox SARS-CoV-2 IgG (RBD & NP) Array offers clinicians an opportunity to discriminate vaccinated individuals from those naturally infected by covid-19.
Read MorePosted by Laurie Bonner | Dec 23, 2020 | Covid 19, Immunoassay Reagents & test Kits |
The Randox SARS-CoV-2 IgG (RBD & NP) Array offers clinicians an opportunity to discriminate vaccinated individuals from those naturally infected by covid-19.
Read MorePosted by Melanie Hamilton-Basich | Dec 17, 2020 | Flow Cytometry Instruments, Hematology Instrumentation, Infectious Diseases, Research |
Researchers concluded that PixCell’s HemoScreen, a miniature, easy-to-use, AI and machine vision-enabled hematology analyzer, can fill the gap in point-of-care diagnostics.
Read MorePosted by Melanie Hamilton-Basich | Dec 15, 2020 | Covid 19 |
The at-home covid-19 test is authorized for individuals two years of age or older, including those not showing symptoms.
Read MorePosted by Melanie Hamilton-Basich | Dec 14, 2020 | Cancer, Company News |
Strata also increased its research and development capacity to continue to expand its portfolio of proprietary molecular profiling tests.
Read MorePosted by Melanie Hamilton-Basich | Dec 11, 2020 | Covid 19, Immunoassay |
The Elecsys SARS-CoV-2 Antigen test is a highly accurate laboratory immunoassay for the in vitro qualitative detection of the nucleocapsid antigen of SARS‑CoV‑2.
Read More